BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 25046748)

  • 1. A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo-response in high-grade serous ovarian cancer.
    Ikoma D; Cardillo N; Devor E; Gonzalez-Bosquet J
    Oncol Lett; 2021 Oct; 22(4):733. PubMed ID: 34429773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Long Non-Coding RNA Polymorphisms in Cancer Chemotherapeutic Response.
    Zhang Z; Gu M; Gu Z; Lou YR
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34199840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.
    Mussazhanova Z; Rogounovitch TI; Saenko VA; Krykpayeva A; Espenbetova M; Azizov B; Kondo H; Matsuda K; Kalmatayeva Z; Issayeva R; Yeleubayeva Z; Madiyeva M; Mukanova A; Sandybayev M; Bolsynbekova S; Kozykenova Z; Yamashita S; Nakashima M
    Front Endocrinol (Lausanne); 2020; 11():543500. PubMed ID: 33551988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-recognition of pseudogenes: From molecular to clinical applications.
    Chen X; Wan L; Wang W; Xi WJ; Yang AG; Wang T
    Theranostics; 2020; 10(4):1479-1499. PubMed ID: 32042317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Sequencing Analysis Reveals Distinctive Non-Coding RNAs When Comparing Tumor Multidrug-Resistant Cells and Extracellular Vesicles with Drug-Sensitive Counterparts.
    Sousa D; Matthiesen R; Lima RT; Vasconcelos MH
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Expression of Pseudogene POU5F1B Affects Diagnosis and Prognosis in Acute Myeloid Leukemia (AML).
    Yi J; Zhou LY; Yi YY; Zhu X; Su XY; Zhao Q; Lin J; Qian J; Deng ZQ
    Med Sci Monit; 2019 Jul; 25():4952-4959. PubMed ID: 31271156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.
    Petrelli F; Berenato R; Turati L; Mennitto A; Steccanella F; Caporale M; Dallera P; de Braud F; Pezzica E; Di Bartolomeo M; Sgroi G; Mazzaferro V; Pietrantonio F; Barni S
    J Gastrointest Oncol; 2017 Feb; 8(1):148-163. PubMed ID: 28280619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population.
    Quan F; Zhang F; Bai Y; Zhou L; Yang H; Li B; Jin T; Li H; Shao Y
    Oncotarget; 2017 Feb; 8(6):10255-10263. PubMed ID: 28052013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lnc-LAMC2-1:1 rs2147578 and CASC8 rs10505477 Polymorphisms with Risk of Childhood Acute Lymphoblastic Leukemia.
    Hashemi M; Bahari G; Naderi M; Sadeghi Bojd S; Taheri M
    Asian Pac J Cancer Prev; 2016 Nov; 17(11):4985-4989. PubMed ID: 28032728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
    Ooi WF; Xing M; Xu C; Yao X; Ramlee MK; Lim MC; Cao F; Lim K; Babu D; Poon LF; Lin Suling J; Qamra A; Irwanto A; Qu Zhengzhong J; Nandi T; Lee-Lim AP; Chan YS; Tay ST; Lee MH; Davies JO; Wong WK; Soo KC; Chan WH; Ong HS; Chow P; Wong CY; Rha SY; Liu J; Hillmer AM; Hughes JR; Rozen S; Teh BT; Fullwood MJ; Li S; Tan P
    Nat Commun; 2016 Sep; 7():12983. PubMed ID: 27677335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially Functional Polymorphisms in POU5F1 Gene Are Associated with the Risk of Lung Cancer in Han Chinese.
    Niu R; Wang Y; Zhu M; Wen Y; Sun J; Shen W; Cheng Y; Zhang J; Jin G; Ma H; Hu Z; Shen H; Dai J
    Biomed Res Int; 2015; 2015():851320. PubMed ID: 26824036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results.
    Yao K; Hua L; Wei L; Meng J; Hu J
    Medicine (Baltimore); 2015 Nov; 94(46):e1884. PubMed ID: 26579801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudogenes in Human Cancer.
    Poliseno L; Marranci A; Pandolfi PP
    Front Med (Lausanne); 2015; 2():68. PubMed ID: 26442270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection.
    Shen L; Du M; Wang C; Gu D; Wang M; Zhang Q; Zhao T; Zhang X; Tan Y; Huo X; Gong W; Xu Z; Chen J; Zhang Z
    Int J Mol Sci; 2014 Jul; 15(7):12764-77. PubMed ID: 25046748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity.
    Hu L; Chen SH; Lv QL; Sun B; Qu Q; Qin CZ; Fan L; Guo Y; Cheng L; Zhou HH
    Int J Environ Res Public Health; 2016 May; 13(6):. PubMed ID: 27249003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
    Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
    Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.
    Ruf C; Thomusch O; Goos M; Makowiec F; Illerhaus G; Ruf G
    BMC Surg; 2014 Jan; 14():5. PubMed ID: 24461063
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.